Patients await your cure.
We make the wait shorter.
Specialists in recombinant
protein therapeutics.
Bionova is a biologics CDMO focused on the development and production of mAbs and other therapeutic proteins using mammalian cell culture processes.
Our team is your team.
With technical depth you’d expect from a larger biologics CDMO, our team offers a flexible, fast, client-first culture that our clients find refreshing.
Dedicated. Capable. Committed.
Bionova fuses technical expertise, best-in-class infrastructure and an attitude that makes problem-solving and client success our highest priority.
News & Happenings
February 4, 2026
Scarab Genomics and Bionova Enter Exclusive Licensing Partnership to Advance High-Efficiency Plasmid DNA Production
January 8, 2026
Bionova Scientific and Syenex Forge Strategic Alliance to Expand Access to High-Quality Plasmid DNA for Advanced Therapies
July 3, 2025
Redefining Quality Culture at Bionova: A New Chapter Begins
May 7, 2025
Bionova Scientific Licenses ATUM’s Proprietary Transposon-Based Gene Delivery Technology to Accelerate & De-Risk Cell Line Development
March 20, 2025
Bionova Appoints Bionique Testing Laboratories as Preferred Provider for Mycoplasma Testing Services for Biologics Manufacturing
February 25, 2025
Bionova R&D Leaders Featured in Contract Pharma Q&A
Get in touch
Let’s chat! Tell us how Bionova might help
your organization move forward.
